Cargando…

Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B

Nasvac (HeberNasvac(®)) is a novel therapeutic vaccine for chronic hepatitis B (CHB). This product is a formulation of the core (HBcAg) and surface (HBsAg) antigens of the hepatitis B virus (HBV), administered by nasal and subcutaneous routes, in a distinctive schedule of immunizations. In the prese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguilar, Julio Cesar, Aguiar, Jorge Agustin, Akbar, Sheikh Mohammad Fazle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787858/ https://www.ncbi.nlm.nih.gov/pubmed/36560498 http://dx.doi.org/10.3390/vaccines10122087

Ejemplares similares

Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac
por: Fernández, Guillermo, et al.
Publicado: (2018)

HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis
por: Fleites, Yoel A, et al.
Publicado: (2021)

Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon
por: Al-Mahtab, Mamun, et al.
Publicado: (2023)

Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2021)

Reginald Heber Fitz, The Exponent of Appendicitis
por: Loveland, John E.
Publicado: (1937)

In Memoriam—Dr. J. Heber Smith
Publicado: (1898)

Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatment
por: Al Mahtab, Mamun, et al.
Publicado: (2023)

Praxisschließung bei fehlender Schutzausrüstung?: Fragen an BVOU-Justitiar Dr. Jörg Heberer
por: Heberer, Jörg, et al.
Publicado: (2020)

Ungeimpftes Personal - geht das?: BVOU-Verbandsjustitiar Dr. Jörg Heberer klärt auf
por: Kuno, Janosch
Publicado: (2022)

Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2023)

The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2021)

Immune therapies against chronic hepatitis B
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)
por: Al Mahtab, Mamun, et al.
Publicado: (2018)

Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG
por: Vázquez-Blomquist, Dania, et al.
Publicado: (2022)

Epidemiology of Hepatitis E Virus in an Urban Community in Dhaka City
por: Rahman, Salimur, et al.
Publicado: (2014)

EDITORIAL
por: Akbar, Sheikh Mohammad Fazle
Publicado: (2019)

Rationale of the Action of Cocaine
Publicado: (1885)

Scientific rationale for a higher dose of nusinersen
por: Finkel, Richard S., et al.
Publicado: (2022)

Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Alarming Levels of Hepatitis C Virus Prevalence among Rohingya Refugees in Bangladesh: Emergency National and International Actions Warranted
por: Mahtab, Mamun Al, et al.
Publicado: (2019)

Recent downhill course of COVID-19 at Rohingya refugee camps in Bangladesh: Urgent action solicited
por: Khan, Sakirul, et al.
Publicado: (2021)

Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders
por: Shiraishi, Kana, et al.
Publicado: (2023)

Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial
por: García-Vega, Yanelda, et al.
Publicado: (2012)

Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
por: Niazi, Sarfaraz
Publicado: (2022)

The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis
por: Stojanovic, Dijana, et al.
Publicado: (2022)

EDITORIAL
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2019)

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA
por: Cohen, Joshua S, et al.
Publicado: (2016)

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale
por: Berry, Colin, et al.
Publicado: (2016)

Ibrutinib combinations in CLL therapy: scientific rationale and clinical results
por: Timofeeva, Natalia, et al.
Publicado: (2021)

Scientific Rationale for the Treatment of Cognitive Deficits from Long COVID
por: Fesharaki Zadeh, Arman, et al.
Publicado: (2023)

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

Co-existence of a pandemic (SARS-CoV-2) and an epidemic (Dengue virus) at some focal points in Southeast Asia: Pathogenic importance, preparedness, and strategy of tackling
por: Khan, Sakirul, et al.
Publicado: (2022)

Integrating economics into the rationale for multisectoral action on obesity
por: Ellis, Vivian L., et al.
Publicado: (2018)

An Outbreak of Acute Hepatitis in a Medical Facility of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2014)

Scientific Evidence and Rationale for the Development of Curcumin and Resveratrol as Nutraceutricals for Joint Health
por: Mobasheri, Ali, et al.
Publicado: (2012)

The Finnish Allergy Programme 2008-2018 - scientific rationale and practical implementation
por: Haahtela, Tari, et al.
Publicado: (2012)

Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale
por: Janssen, Rob, et al.
Publicado: (2019)

Genomic analysis of Hepatitis B virus and its association with disease manifestations in Bangladesh
por: Raihan, Ruksana, et al.
Publicado: (2019)

The Journal in the Horizon of Asia and Europe
por: Fazle Akbar, Sheikh Mohammad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ke26ou59npv5895gjmrgiilitc